ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 229 filers reported holding ARRAY BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $311,643,000 | +422.6% | 6,726,624 | +175.0% | 0.18% | +73.5% |
| Q1 2019 | $59,638,000 | +312.1% | 2,446,153 | +140.9% | 0.10% | +264.3% |
| Q4 2018 | $14,470,000 | -6.0% | 1,015,418 | +0.3% | 0.03% | +12.0% |
| Q3 2018 | $15,395,000 | -1.3% | 1,012,837 | +8.9% | 0.02% | -7.4% |
| Q2 2018 | $15,600,000 | +19.2% | 929,678 | +15.9% | 0.03% | +12.5% |
| Q1 2018 | $13,086,000 | +209.8% | 801,825 | +143.0% | 0.02% | +242.9% |
| Q4 2017 | $4,224,000 | +4.1% | 330,000 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $4,059,000 | +47.0% | 330,000 | 0.0% | 0.01% | +40.0% |
| Q2 2017 | $2,762,000 | -6.4% | 330,000 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $2,950,000 | +1.7% | 330,000 | 0.0% | 0.01% | -16.7% |
| Q4 2016 | $2,901,000 | +30.2% | 330,000 | 0.0% | 0.01% | +50.0% |
| Q3 2016 | $2,228,000 | -5.2% | 330,000 | -50.0% | 0.00% | +100.0% |
| Q2 2016 | $2,350,000 | – | 660,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |